.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Boehringer Ingelheim
Fish and Richardson
Novartis
Baxter
Express Scripts
Healthtrust
Chinese Patent Office
Queensland Health

Generated: November 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062216

« Back to Dashboard
NDA 062216 describes AMOXIL, which is a drug marketed by Dr Reddys Labs Inc and Glaxosmithkline and is included in eight NDAs. It is available from five suppliers. Additional details are available on the AMOXIL profile page.

The generic ingredient in AMOXIL is amoxicillin. There are forty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.

Summary for 062216

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 062216

Ingredient-typePenicillins

Medical Subject Heading (MeSH) Categories for 062216

Suppliers and Packaging for NDA: 062216

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMOXIL
amoxicillin
CAPSULE;ORAL 062216 ANDA Dr Reddys Laboratories Inc 43598-205 43598-205-01 100 CAPSULE in 1 BOTTLE (43598-205-01)
AMOXIL
amoxicillin
CAPSULE;ORAL 062216 ANDA Dr Reddys Laboratories Inc 43598-205 43598-205-05 500 CAPSULE in 1 BOTTLE (43598-205-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Summary for product number 004

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Medtronic
Colorcon
Chinese Patent Office
AstraZeneca
Argus Health
QuintilesIMS
Baxter
US Army
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot